Skip to content
YCS18· Other

Mytos

Robotic human cell manufacturing

ActiveChecked 24h ago
Batch
S18
Status, per YC
Active
Team size
26
HQ
London, England
In S18131 companies, 29% AI
mytos.bioYC profile

Founders

Not read from YC yet; the weekly run fills these in.

Same space

About Mytos

Mytos builds robots for manufacturing human cells. Operators input stem cells, and our platform turns them into specific cells such as neurons and heart cells over multiple weeks. Last year, patients were cured of Parkinson’s, vision loss, and Type 1 diabetes using stem-cell derived cells. We need 1000x the global capacity to produce these cells, and treat millions of patients. But today these Regenerative Medicines are produced by hand, meaning they’re too expensive and don’t scale. Mytos has fully automated production of these cells, making it scalable. We have our first manufacturing deal - neurons for treating Parkinson’s - and we’re in conversations with majority of the other top players.

London, England, United Kingdom

Mytos: questions

Which YC batch was Mytos in?

Mytos was in Y Combinator's Summer 2018 batch (S18).

Is Mytos still active?

Y Combinator lists Mytos as active.

Where is Mytos based?

Mytos lists London, England, United Kingdom as its location on YC's directory.

Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.

Weekly: new YC data, AI and devtools companies and status changes, Mondays.